Koninklijke Philips reported EUR1.21B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Danaher USD 2.16B 87M Sep/2026
Demant DKK 7.09B 1B Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Fresenius EUR 823M 63M Sep/2026
General Electric Aerospace USD 1.09B 40M Sep/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 288.47M 1.65M Sep/2026
GN Store Nord DKK 751M 54M Sep/2026
Hitachi JPY 532.33B 16.94B Sep/2026
Idexx Laboratories USD 293.13M 5.04M Sep/2026
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Koninklijke Philips EUR 1.21B 23M Jun/2026
Medtronic 3.2B 141M Jun/2026
Philips EUR 1.17B 33M Sep/2026
ResMed USD 290.65M 10.86M Jun/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Steris USD 366M 3.7M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 220.72M 7.21M Sep/2026
Terumo JPY 109.58B 120M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026